These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 18938075)

  • 1. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
    Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gd(DO3A-N-alpha-aminopropionate): a versatile and easily available synthon with optimized water exchange for the synthesis of high relaxivity, targeted MRI contrast agents.
    Ferreira MF; Martins AF; Martins JA; Ferreira PM; Tóth E; Geraldes CF
    Chem Commun (Camb); 2009 Nov; (42):6475-7. PubMed ID: 19841814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient relaxivity enhancement in dendritic gadolinium complexes: effective motional coupling in medium molecular weight conjugates.
    Fulton DA; O'Halloran M; Parker D; Senanayake K; Botta M; Aime S
    Chem Commun (Camb); 2005 Jan; (4):474-6. PubMed ID: 15654374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Gd3+-based magnetic resonance imaging contrast agent sensitive to beta-galactosidase activity utilizing a receptor-induced magnetization enhancement (RIME) phenomenon.
    Hanaoka K; Kikuchi K; Terai T; Komatsu T; Nagano T
    Chemistry; 2008; 14(3):987-95. PubMed ID: 17992679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel cholic acid-based contrast enhancement agent for targeted MRI.
    Chong HS; Song HA; Lim S; Macrenaris K; Ma X; Lee H; Bui P; Meade T
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2505-8. PubMed ID: 18337094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
    Xu J; Churchill DG; Botta M; Raymond KN
    Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and physicochemical characterization of Gd-C4-thyroxin-DTPA, a potential MRI contrast agent. Evaluation of its affinity for human serum albumin by proton relaxometry, NMR diffusometry, and electrospray mass spectrometry.
    Henoumont C; Vander Elst L; Laurent S; Muller RN
    J Phys Chem B; 2010 Mar; 114(10):3689-97. PubMed ID: 20175550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging.
    Werner EJ; Datta A; Jocher CJ; Raymond KN
    Angew Chem Int Ed Engl; 2008; 47(45):8568-80. PubMed ID: 18825758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of intravascular contrast agents for MRI using gadolinium chelates.
    Kittigowittana K; Yang CT; Cheah WC; Chuang KH; Tuang CY; Chang YT; Golay X; Bates RW
    ChemMedChem; 2011 May; 6(5):781-7. PubMed ID: 21433294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gd-AAZTA]-: a new structural entry for an improved generation of MRI contrast agents.
    Aime S; Calabi L; Cavallotti C; Gianolio E; Giovenzana GB; Losi P; Maiocchi A; Palmisano G; Sisti M
    Inorg Chem; 2004 Nov; 43(24):7588-90. PubMed ID: 15554621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field.
    Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E
    Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exofacial protein thiols as a route for the internalization of Gd(III)-based complexes for magnetic resonance imaging cell labeling.
    Digilio G; Menchise V; Gianolio E; Catanzaro V; Carrera C; Napolitano R; Fedeli F; Aime S
    J Med Chem; 2010 Jul; 53(13):4877-90. PubMed ID: 20533827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
    Caravan P
    Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadolinium-doped LipoCEST agents: a potential novel class of dual 1H-MRI probes.
    Terreno E; Boffa C; Menchise V; Fedeli F; Carrera C; Castelli DD; Digilio G; Aime S
    Chem Commun (Camb); 2011 Apr; 47(16):4667-9. PubMed ID: 21409237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CNN-Gd(3+) enables cell nucleus molecular imaging of prostate cancer cells: the last 600 nm.
    Heckl S; Debus J; Jenne J; Pipkorn R; Waldeck W; Spring H; Rastert R; von der Lieth CW; Braun K
    Cancer Res; 2002 Dec; 62(23):7018-24. PubMed ID: 12460922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A DTTA-ligated uridine-quantum dot conjugate as a bimodal contrast agent for cellular imaging.
    Park J; Bhuniya S; Lee H; Noh YW; Lim YT; Jung JH; Hong KS; Kim JS
    Chem Commun (Camb); 2012 Mar; 48(26):3218-20. PubMed ID: 22349268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymeric gadolinium chelate magnetic resonance imaging contrast agents: design, synthesis, and properties.
    Ladd DL; Hollister R; Peng X; Wei D; Wu G; Delecki D; Snow RA; Toner JL; Kellar K; Eck J; Desai VC; Raymond G; Kinter LB; Desser TS; Rubin DL
    Bioconjug Chem; 1999; 10(3):361-70. PubMed ID: 10346865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Gd(III)-C-palmitamidomethyl-C'-DOTAMA-C(6)-o-carborane: a new dual agent for innovative MRI/BNCT applications.
    Aime S; Barge A; Crivello A; Deagostino A; Gobetto R; Nervi C; Prandi C; Toppino A; Venturello P
    Org Biomol Chem; 2008 Dec; 6(23):4460-6. PubMed ID: 19005608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro characterization of the Gd complex of [2,6-pyridinediylbis(methylene nitrilo)] tetraacetic acid (PMN-tetraacetic acid) and of its Eu analogue, suitable bimodal contrast agents for MRI and optical imaging.
    Laurent S; Vander Elst L; Wautier M; Galaup C; Muller RN; Picard C
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6230-3. PubMed ID: 17889530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cascade polymeric MRI contrast media derived from poly(ethylene glycol) cores: initial syntheses and characterizations.
    Fu Y; Raatschen HJ; Nitecki DE; Wendland MF; Novikov V; Fournier LS; Cyran C; Rogut V; Shames DM; Brasch RC
    Biomacromolecules; 2007 May; 8(5):1519-29. PubMed ID: 17402781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.